SECONDARY MYELODYSPLASTIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION - REPORT OF 2 CASES

被引:0
|
作者
CHAN, T [1 ]
JUNEJA, S [1 ]
WOLF, M [1 ]
JANUSZEWICZ, E [1 ]
COOPER, I [1 ]
机构
[1] PETER MACCALLUM CANC INST,DEPT HAEMATOL & MED ONCOL,MELBOURNE,VIC 3000,AUSTRALIA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We report two cases of secondary myelodysplastic syndrome (SMDS) which followed successful treatment of a primary malignancy with high-dose chemotherapy supported by reinfusion of autologous stem cells. The SMDS was diagnosed 24 months and 40 months, respectively, following autografting. Both patients lived for 7 months after the diagnosis of SMDS. Our cases support the view that there is an increased risk of SMDS/acute leukemia following autologous marrow transplantation.
引用
收藏
页码:145 / 148
页数:4
相关论文
共 50 条
  • [1] BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKEMIAS
    DEWITTE, T
    GRATWOHL, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (03) : 361 - 364
  • [2] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    BANDINI, G
    ROSTI, G
    CALORI, E
    ALBERTAZZI, L
    TURA, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (03) : 442 - 443
  • [3] ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME COMPLICATING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    BASHIR, S
    COOK, P
    KATZ, M
    MITTELMAN, A
    AHMED, T
    CANCER INVESTIGATION, 1994, 12 (05) : 484 - 487
  • [4] BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKEMIA (SAML) - OUTCOME OF 84 PATIENTS
    LEBLOND, V
    JOUET, JP
    RIBAUD, P
    LEMAIGNAN, C
    SUTTON, L
    KUENTZ, M
    GLUCKMAN, E
    BLAISE, D
    MARIT, G
    LEUKEMIA, 1991, 5 (02) : 179 - 179
  • [5] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR SECONDARY LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    DEWITTE, T
    ZWAAN, F
    HERMANS, J
    VERNANT, J
    KOLB, H
    VOSSEN, J
    LONNQVIST, B
    BEELEN, D
    FERRANT, A
    GMUR, J
    YIN, JL
    TROUSSARD, X
    CAHN, J
    VANLINT, M
    GRATWOHL, A
    BONE MARROW TRANSPLANTATION, 1989, 4 : 38 - 39
  • [6] ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SECONDARY LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES
    DEWITTE, T
    ZWAAN, F
    GRATWOHL, A
    VERNANT, J
    GMUR, J
    YIN, JL
    TROUSARD, X
    CAHN, J
    VANLINT, M
    BONE MARROW TRANSPLANTATION, 1988, 3 : 142 - 143
  • [7] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR 93 PATIENTS WITH MYELODYSPLASTIC SYNDROME
    ANDERSON, JE
    APPELBAUM, FR
    FISHER, LD
    SCHOCH, G
    SHULMAN, H
    ANASETTI, C
    BENSINGER, WI
    BRYANT, E
    BUCKNER, CD
    DONEY, K
    MARTIN, PJ
    SANDERS, JE
    SULLIVAN, KM
    THOMAS, ED
    WITHERSPOON, RP
    HANSEN, JA
    STORB, R
    BLOOD, 1993, 82 (02) : 677 - 681
  • [8] BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES
    BELANGER, R
    GYGER, M
    PERREAULT, C
    BONNY, Y
    STLOUIS, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) : 29 - 33
  • [9] TIMING OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN SECONDARY LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES
    DEWITTE, T
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 469 - 469
  • [10] MYELODYSPLASTIC SYNDROME WITH EOSINOPHILIA IN BONE-MARROW
    MATSUSHIMA, T
    MURAKAMI, H
    SAWAMURA, M
    TAMURA, J
    SAKURA, T
    MATSUMOTO, M
    HIRABAYASHI, H
    MIYAWAKI, S
    SIMANO, S
    SATO, S
    TSUCHIYA, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (04) : 636 - 638